Stock 27F0 KALA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart KALA BIO, Inc. Deutsche Boerse AG

Equities

27F0

US4831192020

Real-time Estimate Tradegate
Other stock markets
 12:01:00 03/07/2024 BST 		5-day change 1st Jan Change
6.243 EUR -1.14% Intraday chart for KALA BIO, Inc. +42.86% -7.04%
06-28 KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP CI
06-27 Top Midday Gainers MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
 351B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 323B
ABBVIE INC. Stock AbbVie Inc.
 293B
  1. Stock Market
  2. Equities
  3. KALA Stock
  4. 27F0 Stock
  5. Charts KALA BIO, Inc.
  6. Sector Chart